Ameritas Investment Partners
LRMR icon

Ameritas Investment Partners’s Larimar Therapeutics LRMR Stock Holding History

Ameritas Investment Partners’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6K Hold
4,121
– – ﹤0.01% 2955
2026
Q1 		$18.5K Hold
4,121
– – ﹤0.01% 2625
2025
Q4 		$15.7K Hold
4,121
– – ﹤0.01% 2752
2025
Q3 		$13.3K Hold
4,121
– – ﹤0.01% 2856
2025
Q2 		$11.9K Hold
4,121
– – ﹤0.01% 2917
2025
Q1 		$8.86K Hold
4,121
– – ﹤0.01% 2862
2024
Q4 		$15.9K Hold
4,121
– – ﹤0.01% 2726
2024
Q3 		$27K Hold
4,121
– – ﹤0.01% 2504
2024
Q2 		$29.9K Buy
4,121
+2,003
+95% +$15.3K ﹤0.01% 2429
2024
Q1 		$16.1K Hold
2,118
– – ﹤0.01% 2651
2023
Q4 		$9.64K Hold
2,118
– – ﹤0.01% 2850
2023
Q3 		$8.37K Hold
2,118
– – ﹤0.01% 2886
2023
Q2 		$6.63K Buy
+2,118
New +$8.64K ﹤0.01% 2995
2019
Q2 		– Sell
-167
Closed -$5K – 3088
2019
Q1 		$5K Hold
167
– – ﹤0.01% 2859
2018
Q4 		$10K Hold
167
– – ﹤0.01% 2664
2018
Q3 		$23K Hold
167
– – ﹤0.01% 2440
2018
Q2 		$21K Buy
+167
New +$14.2K ﹤0.01% 2486
2017
Q2 		– Sell
-106
Closed -$6K – 3024
2017
Q1 		$6K Buy
+106
New +$5.26K ﹤0.01% 2812

Other funds holding LRMR

Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Ameritas Investment Partners's LRMR Position: Q2 2026 in Review

Ameritas Investment Partners held its Larimar Therapeutics (LRMR) position steady in Q2 2026 at 4,121 shares worth $12.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2955.

Ameritas Investment Partners first reported a position in LRMR in Q1 2017 and has held it in 18 quarters since. The position peaked at $29.9K in Q2 2024. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Ameritas Investment Partners held 4,121 shares of Larimar Therapeutics worth $12.6K as of Q2 2026.
  • Ameritas Investment Partners left its Larimar Therapeutics share count unchanged in Q2 2026.
  • Larimar Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2955 holding.
  • Ameritas Investment Partners first reported a position in Larimar Therapeutics in Q1 2017 and has held it in 18 quarters since.
  • Ameritas Investment Partners's Larimar Therapeutics position peaked at $29.9K in Q2 2024.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.